Fusion of EML4 and ALK Is Associated With Development of Lung Adenocarcinomas Lacking EGFR and KRAS Mutations and Is Correlated With ALK Expression

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-9-188